Ulcerative Colitis Clinical Trial Results

Browse clinical trials for Ulcerative Colitis by phase, sponsor and reported results. Data from ClinicalTrials.gov.

• A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
  Phase 2/3 · Janssen Research & Development, LLC · Active, not recruiting · Nov 18, 2024
• GI Permeability Change in Response to Aquamin®
  Phase 2 · James Varani · Completed · Jun 8, 2026
• A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Coliti
  Phase 2 · Hoffmann-La Roche · Completed · Dec 16, 2025
• A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
  Phase 3 · Janssen Research & Development, LLC · Active, not recruiting · Dec 9, 2025
• A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely A
  Phase 3 · Janssen Research & Development, LLC · Active, not recruiting · Nov 14, 2025
• Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Ethnicity in the Treatment of UC
  N/A · First Affiliated Hospital of Kunming Medical University · Completed · Jun 30, 2026
• ENhanced Recovery in CHildren Undergoing Surgery
  Phase 3 · Northwestern University · Completed · Jun 23, 2026
• Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis
  Phase 2 · OSE Immunotherapeutics · Completed · Jun 23, 2026
• Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis
  Phase 2 · AstraZeneca · Terminated · Jun 23, 2026
• Open-label Extension Study of Brazikumab in Ulcerative Colitis
  Phase 2 · AstraZeneca · Terminated · Jun 23, 2026
• A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe
  Phase 3 · Takeda · Active, not recruiting · Jun 15, 2026
• Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis
  Phase 2 · AbbVie · Terminated · Jun 15, 2026
• A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis
  Phase 3 · Eli Lilly and Company · Completed · Sep 30, 2025
• Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis
  Phase 4 · Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa · Terminated · Feb 21, 2025
• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
  Phase 3 · Eli Lilly and Company · Completed · Nov 25, 2022

Trials by condition

Lung CancerNon-Small Cell Lung CancerBreast CancerColorectal CancerGastric CancerLiver CancerPancreatic CancerProstate CancerOvarian CancerMelanomaLeukemiaLymphomaMultiple MyelomaGlioblastomaType 2 DiabetesObesityHypertensionHeart FailureAtrial FibrillationStrokeChronic Kidney DiseaseNASH / MASHAlzheimer’s DiseaseParkinson’s DiseaseMultiple SclerosisDepressionEpilepsyALSRheumatoid ArthritisPsoriasisAtopic DermatitisCrohn’s DiseaseUlcerative ColitisLupusAsthmaCOPD

All trials